[
  {
    "ts": null,
    "headline": "Jim Cramer Says Merck & Co. (MRK) Has Been a One-way Stock Even Though CEO Rob Davis Has Done Some Terrific Things",
    "summary": "We recently compiled a list of the Jim Cramer Discussed These 12 Stocks Amidst The DeepSeek AI Selloff. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks that Jim Cramer discussed. In the episode of CNBC’s Squawk on the Street aired on the […]",
    "url": "https://finnhub.io/api/news?id=a58371c157bb5fdd93d9dce2b06dce1e7d600c45b6cd3238811aa16ab3d0f9c7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738259146,
      "headline": "Jim Cramer Says Merck & Co. (MRK) Has Been a One-way Stock Even Though CEO Rob Davis Has Done Some Terrific Things",
      "id": 132505702,
      "image": "https://s.yimg.com/ny/api/res/1.2/krpa0cobX2AdeFb7DJ59pg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/3c1e6d485df373db04a8fd19fdaf6c3a",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the Jim Cramer Discussed These 12 Stocks Amidst The DeepSeek AI Selloff. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other stocks that Jim Cramer discussed. In the episode of CNBC’s Squawk on the Street aired on the […]",
      "url": "https://finnhub.io/api/news?id=a58371c157bb5fdd93d9dce2b06dce1e7d600c45b6cd3238811aa16ab3d0f9c7"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know",
    "summary": "Merck (MRK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
    "url": "https://finnhub.io/api/news?id=4d9f1f342a3de37a901484a0004d5ec6abfb3fc1c62fc27374cbf380b8b9b714",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738245623,
      "headline": "Merck & Co., Inc. (MRK) is Attracting Investor Attention: Here is What You Should Know",
      "id": 132505703,
      "image": "https://media.zenfs.com/en/zacks.com/f541c90e0d995722d10914cb76a7c653",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck (MRK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.",
      "url": "https://finnhub.io/api/news?id=4d9f1f342a3de37a901484a0004d5ec6abfb3fc1c62fc27374cbf380b8b9b714"
    }
  },
  {
    "ts": null,
    "headline": "Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final Analysis",
    "summary": "RAHWAY, N.J., January 30, 2025--Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final Analysis",
    "url": "https://finnhub.io/api/news?id=1be9441be5dc7379bf0944dd04496bd3280ef2d2baedf5c1df5eaa2ac38e0483",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738237500,
      "headline": "Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final Analysis",
      "id": 132505704,
      "image": "https://media.zenfs.com/en/business-wire.com/9418b1b4270968dfd0a2d366983fbf7b",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., January 30, 2025--Merck Announces Decision to Stop Phase 3 HYPERION Trial Evaluating WINREVAIR™ (sotatercept-csrk) Early and Move to Final Analysis",
      "url": "https://finnhub.io/api/news?id=1be9441be5dc7379bf0944dd04496bd3280ef2d2baedf5c1df5eaa2ac38e0483"
    }
  },
  {
    "ts": null,
    "headline": "Merck Stops Winrevair Study Early Amid Positive Results",
    "summary": "By Colin Kellaher Merck & Co. has ended another late-stage study of its Winrevair treatment for pulmonary arterial hypertension, or PAH, early due to strong evidence of the drug's benefit. ...",
    "url": "https://finnhub.io/api/news?id=51da229411eb42e5f0c417a4edd3fb7700f1f592c99279f7826da0a493553fc8",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738229416,
      "headline": "Merck Stops Winrevair Study Early Amid Positive Results",
      "id": 132499578,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "By Colin Kellaher Merck & Co. has ended another late-stage study of its Winrevair treatment for pulmonary arterial hypertension, or PAH, early due to strong evidence of the drug's benefit. ...",
      "url": "https://finnhub.io/api/news?id=51da229411eb42e5f0c417a4edd3fb7700f1f592c99279f7826da0a493553fc8"
    }
  },
  {
    "ts": null,
    "headline": "Merck: Phase III study on Winrevair halted",
    "summary": "Merck announced on Thursday that it had decided to discontinue a Phase III clinical trial of its Winrevair pulmonary arterial hypertension treatment in view of the positive results obtained in other...",
    "url": "https://finnhub.io/api/news?id=b11c11d030658b88cc0c70b5ef6a910e18712c8e11a8227b75712f5d69de22e8",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1738224980,
      "headline": "Merck: Phase III study on Winrevair halted",
      "id": 132499159,
      "image": "",
      "related": "MRK",
      "source": "Finnhub",
      "summary": "Merck announced on Thursday that it had decided to discontinue a Phase III clinical trial of its Winrevair pulmonary arterial hypertension treatment in view of the positive results obtained in other...",
      "url": "https://finnhub.io/api/news?id=b11c11d030658b88cc0c70b5ef6a910e18712c8e11a8227b75712f5d69de22e8"
    }
  }
]